APASL HCV guidelines of virus-eradicated patients by DAA on how to monitor HCC occurrence and HBV reactivation

In the direct-acting antiviral (DAA) era for hepatitis C virus (HCV) infection, sustained virological response (SVR) is very high, but close attention must be paid to the possible occurrence of hepatocellular carcinoma (HCC) and reactivation of hepatitis B virus (HBV) in patients with co-infection w...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Hepatol Int
Autori principali: Kanda, Tatsuo, Lau, George K. K., Wei, Lai, Moriyama, Mitsuhiko, Yu, Ming-Lung, Chuang, Wang-Long, Ibrahim, Alaaeldin, Lesmana, Cosmas Rinaldi Adithya, Sollano, Jose, Kumar, Manoj, Jindal, Ankur, Sharma, Barjesh Chander, Hamid, Saeed S., Kadir Dokmeci, A., Mamun-Al-Mahtab, McCaughan, Geoffrey W., Wasim, Jafri, Crawford, Darrell H. G., Kao, Jia-Horng, Ooka, Yoshihiko, Yokosuka, Osamu, Sarin, Shiv Kumar, Omata, Masao
Natura: Artigo
Lingua:Inglês
Pubblicazione: Springer India 2019
Soggetti:
Guidelines
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6861433/
https://ncbi.nlm.nih.gov/pubmed/31541423
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12072-019-09988-7
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi